CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-28 | Stonehouse Jon P President & CEO | Option exercise | +56,949 | $3.26 | $186K | 698,316 |
| 2018-02-28 | Stonehouse Jon P President & CEO | Shares withheld for taxes | −43,224 | $4.97 | $215K | 655,092 |
| 2018-02-28 | Stonehouse Jon P President & CEO | Option exercise · Emp. Stock Option (Right to Buy) | −56,949 | 0 | ||
| 2018-02-28 | Barnes Alane P VP, General Counsel & Corp Sec | Option exercise | +6,709 | $3.26 | $22K | 85,768 |
| 2018-02-28 | Barnes Alane P VP, General Counsel & Corp Sec | Option exercise · Emp. Stock Option (Right to Buy) | −6,709 | 0 | ||
| 2018-01-20 | Barnes Alane P VP, General Counsel & Corp Sec | Shares withheld for taxes | −1,961 | $5.59 | $11K | 77,129 |
| 2018-01-20 | Babu Yarlagadda S Senior VP - Drug Discovery | Shares withheld for taxes | −3,872 | $5.59 | $22K | 99,996 |
| 2018-01-20 | Sheridan William P Senior VP - CMO | Shares withheld for taxes | −4,628 | $5.59 | $26K | 18,058 |
| 2018-01-20 | STAAB THOMAS R II Senior Vice President and CFO | Shares withheld for taxes | −3,979 | $5.59 | $22K | 137,383 |
| 2018-01-20 | Stonehouse Jon P President & CEO | Shares withheld for taxes | −9,584 | $5.59 | $54K | 638,367 |
Page 38 of 38 · 750 trades